Therapeutic Area | MeSH |
---|---|
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
HALFLYTELY | Braintree Laboratories | N-021551 DISCN | 2010-07-16 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
GOLYTELY | Braintree Laboratories | N-019011 RX | 1984-07-13 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PLENVU | Salix Pharmaceuticals | N-209381 RX | 2018-05-04 | 1 products, RLD, RS |
MOVIPREP | Salix Pharmaceuticals | N-021881 RX | 2006-08-02 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NULYTELY | Braintree Laboratories | N-019797 RX | 1991-04-22 | 1 products, RLD, RS |
NULYTELY-FLAVORED | Braintree Laboratories | N-019797 RX | 1994-11-18 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SUFLAVE | Braintree Laboratories | N-215344 RX | 2023-06-15 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SUCLEAR | Braintree Laboratories | N-203595 DISCN | 2013-01-18 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
basic care clearlax | ANDA | 2023-01-24 |
berkley and jensen clearlax | ANDA | 2023-05-12 |
care one clearlax | ANDA | 2023-02-27 |
careone clearlax | ANDA | 2024-05-19 |
clear lax | ANDA | 2024-12-02 |
clearlax | ANDA | 2025-06-11 |
comfortlax | ANDA | 2025-03-12 |
dg health clearlax | ANDA | 2023-05-04 |
discount drug mart | ANDA | 2025-03-24 |
easylax | ANDA | 2024-12-03 |
Expiration | Code | ||
---|---|---|---|
MAGNESIUM SULFATE / POLYETHYLENE GLYCOL 3350 / POTASSIUM CHLORIDE / SODIUM CHLORIDE / SODIUM SULFATE, SUFLAVE, BRAINTREE LABS | |||
2026-06-15 | NP |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Plenvu, Salix | |||
8999313 | 2033-09-10 | DP | |
9326969 | 2033-09-10 | U-2310 | |
9707297 | 2033-09-10 | DP | |
10016504 | 2033-09-10 | DP | |
10918723 | 2033-09-10 | U-2310 | |
9592252 | 2032-08-11 | DP | U-2310 |
10646512 | 2032-03-25 | DP | |
10780112 | 2032-03-09 | DP | |
10792306 | 2032-03-09 | DP | U-2310 |
11529368 | 2032-03-09 | DP | U-2310 |
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Moviprep, Salix Pharms | |||
7169381 | 2024-09-01 | DS, DP | |
7658914 | 2024-09-01 | DS, DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Constipation | D003248 | — | K59.0 | 2 | 8 | 8 | 29 | 9 | 55 |
Colonoscopy | D003113 | — | — | — | 2 | 13 | 13 | 12 | 40 |
Colonic neoplasms | D003110 | — | C18 | 1 | 1 | 4 | 1 | 1 | 7 |
Colorectal neoplasms | D015179 | — | — | 1 | 1 | 1 | 2 | 1 | 6 |
Crohn disease | D003424 | EFO_0000384 | K50 | 2 | 4 | — | 1 | — | 5 |
Colonic polyps | D003111 | — | K63.5 | — | — | — | 2 | 2 | 4 |
Gastrointestinal diseases | D005767 | — | — | — | 2 | — | 1 | 1 | 4 |
Digestive system diseases | D004066 | EFO_0000405 | K92.9 | — | 2 | — | 1 | 1 | 4 |
Brain diseases | D001927 | — | G93.40 | — | — | — | 1 | 2 | 3 |
Hepatic encephalopathy | D006501 | — | K72.91 | — | — | — | 1 | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | 3 | — | — | 4 |
Infections | D007239 | EFO_0000544 | — | — | 2 | 2 | — | — | 3 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | 1 | 2 | — | — | 3 |
Communicable diseases | D003141 | — | — | — | 1 | 1 | — | — | 2 |
Immunologic deficiency syndromes | D007153 | — | D84.9 | — | 1 | 1 | — | — | 2 |
Critical illness | D016638 | — | — | — | — | 1 | — | 1 | 2 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | 1 | 1 | — | — | 1 |
Clostridioides difficile | D016360 | NCBITaxon_1496 | — | — | 1 | 1 | — | — | 1 |
Endoscopy | D004724 | — | — | — | — | 1 | — | — | 1 |
Hiv-1 | D015497 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Intestinal diseases | D007410 | — | K63.9 | — | 2 | — | — | 2 | 4 |
Syndrome | D013577 | — | — | 1 | 1 | — | — | 1 | 2 |
Diarrhea | D003967 | — | R19.7 | — | 2 | — | — | — | 2 |
Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | 2 | — | — | — | 2 |
Autism spectrum disorder | D000067877 | — | F84.0 | — | 2 | — | — | — | 2 |
Pervasive child development disorders | D002659 | EFO_0003756 | F84 | — | 2 | — | — | — | 2 |
Sjogren's syndrome | D012859 | EFO_0000699 | M35.0 | 1 | 1 | — | — | — | 1 |
Wounds and injuries | D014947 | — | T14.8 | 1 | 1 | — | — | — | 1 |
Lacerations | D022125 | — | — | 1 | 1 | — | — | — | 1 |
Peripheral nerve injuries | D059348 | — | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic ductal carcinoma | D021441 | — | — | 1 | — | — | — | — | 1 |
Adenocarcinoma | D000230 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 3 | 3 |
Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | — | — | 1 | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | — | — | 1 | 1 |
Pregnancy rate | D018873 | — | — | — | — | — | — | 1 | 1 |
Hemorrhoids | D006484 | EFO_0009552 | K64 | — | — | — | — | 1 | 1 |
Fecal incontinence | D005242 | — | R15 | — | — | — | — | 1 | 1 |
Digestive system endoscopy | D016145 | — | — | — | — | — | — | 1 | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | — | 1 | 1 |
Pseudomembranous enterocolitis | D004761 | EFO_1001314 | A04.7 | — | — | — | — | 1 | 1 |
Hyponatremia | D007010 | — | E87.1 | — | — | — | — | 1 | 1 |
Drug common name | Polyethylene glycol 3350 |
INN | macrogol |
Description | Macrogol, also known as polyethylene glycol (PEG), is used as a medication to treat constipation in children and adults. It is taken by mouth. Benefits usually occur within three days. Generally it is only recommended for up to two weeks. It is also used as an excipient. It is also used to clear the bowels (known as "bowel prep") before a colonoscopy, when the onset of the laxative effect is more rapid, typically within an hour.
|
Classification | Small molecule |
Drug class | Osmotic laxative |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201479 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB09287 |
UNII ID | 3WJQ0SDW1A (ChemIDplus, GSRS) |